Galmed Pharmaceuticals Ltd. (GLMD)
NASDAQ·Healthcare·Biotechnology
$0.59
-5.80%
Mkt Cap $3.37M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 31, 2026 | $1.30M | — | — | -$0.38 | -$0.92 | -142.11% | — | — |
| Q4 2025 Nov 26, 2025 | $1.37M | — | — | -$0.54 | -$0.33 | +38.89% | — | — |
| Q3 2025 Aug 28, 2025 | $1.45M | — | — | -$0.83 | $0.63 | +175.90% | — | — |
| Q2 2025 May 22, 2025 | $1.54M | $1.54M | +0.00% | -$0.89 | -$0.62 | +30.34% | — | — |
| Q2 2025 Apr 2, 2025 | — | $1.64M | — | — | -$11.76 | — | — | — |
| Q4 2024 Nov 14, 2024 | — | — | — | — | -$2.31 | — | — | — |
| Q3 2024 Aug 28, 2024 | — | — | — | — | $2.16 | — | — | — |
| Q2 2024 May 30, 2024 | — | — | — | — | -$2.76 | — | — | — |
| Q2 2024 Apr 4, 2024 | — | — | — | -$0.32 | -$11.76 | -3575.00% | — | — |
| Q4 2023 Nov 22, 2023 | — | — | — | -$0.27 | -$2.88 | -966.67% | — | — |
| Q3 2023 Aug 9, 2023 | — | — | — | -$0.34 | -$11.40 | -3252.94% | — | — |
| Q2 2023 Jun 1, 2023 | — | — | — | -$1.50 | -$13.09 | -772.67% | — | — |
| Q1 2023 Mar 29, 2023 | — | — | — | -$0.14 | -$18.00 | -12757.14% | — | — |
| Q4 2022 Nov 16, 2022 | — | — | — | -$27.00 | -$37.80 | -40.00% | — | — |
| Q3 2022 Aug 4, 2022 | — | — | — | -$41.40 | -$27.00 | +34.78% | — | — |
| Q2 2022 May 17, 2022 | — | — | — | -$59.39 | -$43.20 | +27.26% | — | — |
| Q2 2022 May 2, 2022 | — | — | — | — | -$4.45 | — | — | — |
| Q4 2021 Nov 8, 2021 | — | — | — | -$71.99 | -$55.79 | +22.50% | — | — |
| Q3 2021 Aug 5, 2021 | — | — | — | -$73.79 | -$59.39 | +19.51% | — | — |
| Q2 2021 May 13, 2021 | — | — | — | -$79.19 | -$68.39 | +13.64% | — | — |